279 related articles for article (PubMed ID: 21556807)
1. Evidence-based statin prescription for cardiovascular protection in renal impairment.
Fabbian F; De Giorgi A; Pala M; Tiseo R; Manfredini R; Portaluppi F
Clin Exp Nephrol; 2011 Aug; 15(4):456-63. PubMed ID: 21556807
[TBL] [Abstract][Full Text] [Related]
2. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
[TBL] [Abstract][Full Text] [Related]
3. Statins in chronic kidney disease: what do meta-analyses tell us?
Upadhyay A
Clin Exp Nephrol; 2014 Apr; 18(2):278-81. PubMed ID: 24158229
[TBL] [Abstract][Full Text] [Related]
4. Is lipid management effective for all stages of CKD?
Ku E; Campese V
Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
[TBL] [Abstract][Full Text] [Related]
5. Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.
Kanbay M; Turgut F; Covic A; Goldsmith D
J Nephrol; 2009; 22(5):598-609. PubMed ID: 19809992
[TBL] [Abstract][Full Text] [Related]
6. Ezetimibe as a potential treatment for dyslipidemia associated with chronic renal failure and renal transplant.
Ahmed MH; Khalil AA
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1021-9. PubMed ID: 21060168
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.
Athyros VG; Tziomalos K; Karagiannis A
Expert Rev Cardiovasc Ther; 2015; 13(9):1059-66. PubMed ID: 26206619
[TBL] [Abstract][Full Text] [Related]
8. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
9. Statins in the management of dyslipidemia associated with chronic kidney disease.
Epstein M; Vaziri ND
Nat Rev Nephrol; 2012 Feb; 8(4):214-23. PubMed ID: 22349484
[TBL] [Abstract][Full Text] [Related]
10. Dyslipidemia in chronic kidney disease: are statins still indicated in reduction cardiovascular risk in patients on dialysis treatment?
Scarpioni R; Ricardi M; Melfa L; Cristinelli L
Cardiovasc Ther; 2010 Dec; 28(6):361-8. PubMed ID: 20553296
[TBL] [Abstract][Full Text] [Related]
11. Statins for treatment of dyslipidemia in chronic kidney disease.
Shurraw S; Tonelli M
Perit Dial Int; 2006; 26(5):523-39. PubMed ID: 16973506
[TBL] [Abstract][Full Text] [Related]
12. The dyslipidemia of chronic renal disease: effects of statin therapy.
Ozsoy RC; van Leuven SI; Kastelein JJ; Arisz L; Koopman MG
Curr Opin Lipidol; 2006 Dec; 17(6):659-66. PubMed ID: 17095911
[TBL] [Abstract][Full Text] [Related]
13. Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.
Rysz J; Gluba-Brzózka A; Banach M; Więcek A
Int Urol Nephrol; 2015 May; 47(5):805-13. PubMed ID: 25758011
[TBL] [Abstract][Full Text] [Related]
14. Dyslipidemia in patients with chronic kidney disease.
Hager MR; Narla AD; Tannock LR
Rev Endocr Metab Disord; 2017 Mar; 18(1):29-40. PubMed ID: 28000009
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease and statins: improving cardiovascular outcomes.
Walker DB; Walker TJ; Jacobson TA
Curr Atheroscler Rep; 2009 Jul; 11(4):301-8. PubMed ID: 19500494
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease in patients with renal disease: the role of statins.
Fellström B; Holdaas H; Jardine AG; Svensson MK; Gottlow M; Schmieder RE; Zannad F;
Curr Med Res Opin; 2009 Jan; 25(1):271-85. PubMed ID: 19210158
[TBL] [Abstract][Full Text] [Related]
17. Statins in chronic kidney disease: cardiovascular risk and kidney function.
Deedwania PC
Postgrad Med; 2014 Jan; 126(1):29-36. PubMed ID: 24393749
[TBL] [Abstract][Full Text] [Related]
18. [Statins: what is their place in the treatment of chronic kidney insufficiency?].
Ponte B; Bourquin V; Stoermann-Chopard C
Rev Med Suisse; 2009 Feb; 5(192):463-4, 466-8. PubMed ID: 19317313
[TBL] [Abstract][Full Text] [Related]
19. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
[TBL] [Abstract][Full Text] [Related]
20. Dyslipidemia in Patients with Kidney Disease.
Thobani A; Jacobson TA
Cardiol Clin; 2021 Aug; 39(3):353-363. PubMed ID: 34247749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
